US Patent 9585373 Genetically modified major histocompatibility complex mice
Patent 9585373 was granted and assigned to Regeneron Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 8, 2014
Date of Patent
March 7, 2017
Patent Applicant
Patent Application Number
14455237
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9585373 Genetically modified major histocompatibility complex mice
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.